PERSPECTA

News from every angle

← Back to headlines

United Therapeutics Board Approves $2B Share Repurchase, Prices $1.5B ASR

United Therapeutics' board of directors has approved a new $2 billion share repurchase authorization and priced a $1.5 billion accelerated share repurchase (ASR) program.

9 Mar, 11:37 — 9 Mar, 11:37
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed120d ago

United Therapeutics's board approves new $2B repurchase authorization; prices $1.5B ASR

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Study Reveals High Exhaustion Levels Among Filipino Workers

just now

Pag-Ibig Fund Lowers Promo Rates, Increases Loan Cap

just now

Angat Dam Water Level Dips, NIA Implements Contingency Measures

just now